Navigation Links
Global Med Technologies(R) Inc. to Announce Third Quarter Results On October 30th - Conference Call to Follow Release
Date:10/16/2007

DENVER, Oct. 16 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that it will report its third quarter results on Tuesday, October 30, 2007, before the market open. The Company will host a conference call at 4:30 p.m. EDT on the same day.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

Conference Call Details:

Dr. Mick Ruxin, Chief Executive Officer, Tom Marcinek, President and Chief Operating Office, and Darren Craig, Manager of Finance, will discuss the third quarter results and will be available to answer questions. The conference call will be held on Tuesday, October 30, 2007, at 4:30 p.m. EST.

Interested parties are welcome to call the telephone numbers listed below, five minutes prior to the start of the conference call. Callers within the US should call: 1-866 789-9224. Callers that are outside of the US should call: 1-706 679-9621. Callers should reference "Global Med Technologies Earnings Conference Call" to the conference call operator, and the conference call ID no. is: 20490215.

An automated replay of the conference call will be available from October 30th at 5:30 p.m. (EDT) until November 1st at 11:59 p.m. (EDT). To access the replay, please call 1-800 642-1687 if within the US. Callers that are located outside of the US should call: 1-706 645-9291 and enter Global Med's access code of 20490215.

The replay of the conference call will be available from November 1st onward at Global Med's website at http://www.globalmedtech.com.

About Global Med Technologies, Inc.

Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.

For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com, http://www.peoplemed.com and http://www.wyndgate.com .

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.


'/>"/>
SOURCE Global Med Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Skin Cancer Research To Go Global
2. Dementia - a global problem
3. Obesity a global problem
4. Suggestions to reduce global heart disease burden
5. Drop in global deaths from measles
6. First global SARS meet opens
7. SARS-Free Taiwan to Mark End Phase of Global Fight
8. Prevent Global Warming by Becoming A Vegetarian
9. India To March Ahead in The Global HealthCare Competition
10. Global Outbreak Of Bird Flu Warning By Chinese Scientist
11. TWO India Doctors Listed in TIME for Contribution to Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New ... sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory Board., ... the clinic from a small start-up to number 78 in the country based on ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse practitioners ... as their value increases in the healthcare workforce, according to a survey recently ... boards, career fairs, and candidate leads to healthcare employers of physicians and advanced ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Israel , March 28, 2017 Emosis ... This new business entity, Emosis Ltd, headquartered in Tel ... of novel assays complementing the mother company existing technology platform and ... and sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. ...
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: